CORRESP Filing
MANGOCEUTICALS, INC.
Date: June 20, 2025 · CIK: 0001938046 · Accession: 0001641172-25-015822
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288039
Letter
Re: Mangoceuticals, Inc.
June 20, 2025
VIA EDGAR
Division of Corporation Finance
U.S. Securities & Exchange Commission
F Street, NE
Washington, DC 20549
Attn: Office of Industrial Applications and Services
Registration Statement on Form S-3
Initially filed on June 13, 2025 File No. 333-288039
Acceleration Request
Request Date : Tuesday, June 24, 2025
Request Time : 4:00 p.m. Eastern Time (or as soon thereafter as practicable)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Mangoceuticals, Inc. (the " Registrant ") hereby requests that the United States Securities and Exchange Commission (the " Commission ") take appropriate action to cause the above-captioned Registration Statement (the " Registration Statement ") to become effective on Tuesday, June 24, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. This Acceleration Request replaces the prior Acceleration Request filed earlier today which inadvertently failed to include a file number for the Registration Statement.
The Registrant hereby authorizes David M. Loev and/or John S. Gillies of The Loev Law Firm, PC, to orally modify or withdraw this request for acceleration.
Once the Registration Statement has been declared effective, please orally confirm that event with David M. Loev of The Loev Law Firm, PC, corporate counsel to the Registrant, at (832) 930-6432.
Sincerely,
/s/ Jacob
Cohen
Show Raw Text
CORRESP 1 filename1.htm June 20, 2025 VIA EDGAR Division of Corporation Finance U.S. Securities & Exchange Commission 100 F Street, NE Washington, DC 20549 Attn: Office of Industrial Applications and Services Re: Mangoceuticals, Inc. Registration Statement on Form S-3 Initially filed on June 13, 2025 File No. 333-288039 Acceleration Request Request Date : Tuesday, June 24, 2025 Request Time : 4:00 p.m. Eastern Time (or as soon thereafter as practicable) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Mangoceuticals, Inc. (the " Registrant ") hereby requests that the United States Securities and Exchange Commission (the " Commission ") take appropriate action to cause the above-captioned Registration Statement (the " Registration Statement ") to become effective on Tuesday, June 24, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. This Acceleration Request replaces the prior Acceleration Request filed earlier today which inadvertently failed to include a file number for the Registration Statement. The Registrant hereby authorizes David M. Loev and/or John S. Gillies of The Loev Law Firm, PC, to orally modify or withdraw this request for acceleration. Once the Registration Statement has been declared effective, please orally confirm that event with David M. Loev of The Loev Law Firm, PC, corporate counsel to the Registrant, at (832) 930-6432. Sincerely, /s/ Jacob Cohen Jacob Cohen Chief Executive Officer